Panion & Bf Biotech Stock Forecast for 2023 - 2025 - 2030
Updated on 05/09/2024
Panion & Bf Biotech Fair Value Forecast for 2023 - 2025 - 2030
In the last two years, Panion & Bf Biotech's Price has decreased from NT$16.93 to NT$0.00 – a 100.00% drop! In the next year, analysts believe that Fair Value will reach NT$0.00 – an increase of 100.00%. For the next six years, the forecast is forFair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 1795 Stock Forecast | Lotus Pharmaceutical | Buy |
16
|
NT$282.00 | Buy/Sell | NT$339.40 | 21.99% |
| 6472 Stock Forecast | Bora Pharmaceuticals Co., LTD. | Outperform |
15
|
NT$715.00 | Buy/Sell | NT$703.67 | 18.88% |
| 4123 Stock Forecast | Center Laboratories | - |
10
|
NT$46.70 | Buy/Sell | NT$0.00 | -100.00% |
| 1789 Stock Forecast | ScinoPharm Taiwan | Hold |
18
|
NT$27.60 | Buy/Sell | NT$26.00 | -5.80% |
| 4105 Stock Forecast | TTY Biopharm Company | Hold |
18
|
NT$78.00 | Buy/Sell | NT$86.00 | 10.90% |
Panion & Bf Biotech Revenue Forecast for 2023 - 2025 - 2030
Panion & Bf Biotech's Revenue has seen growth In the last two years, going from NT$1.57B to NT$2.40B – a gain of 52.91% The next year, 0 experts forecast that Panion & Bf Biotech's Revenue will decrease by 19.66%, reaching NT$1.93B. In 2030, professionals predict that Panion & Bf Biotech's Revenue will decrease by 17.58%, reaching NT$1.98B.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 6620 Stock Forecast | Handa Pharmaceuticals | Buy |
4
|
NT$135.50 | Buy/Sell | NT$200.00 | 47.60% |
| 8436 Stock Forecast | TCI | Hold |
16
|
NT$146.50 | Buy/Sell | NT$185.20 | 16.04% |
| 4114 Stock Forecast | Synmosa Biopharma | - |
14
|
NT$39.10 | Buy/Sell | NT$36.00 | -100.00% |
.jpg)
Panion & Bf Biotech Dividend per Share Forecast for 2023 - 2025 - 2030
In the last two years, Dividend per Share for Panion & Bf Biotech has grown by 185.71%, going from NT$0.70 to NT$2.00. According to the 0 analysts polled, in the next year, Panion & Bf Biotech's Dividend per Share will fall by 34.44%, reaching NT$1.31. By 2030, professionals believe that Panion & Bf Biotech's Dividend per Share will have decreased by 27.74%, falling to NT$1.45.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 6576 Stock Forecast | Foresee Pharmaceuticals | Buy |
6
|
NT$93.80 | Buy/Sell | NT$122.25 | 63.11% |
| 6586 Stock Forecast | CHO Pharma | - |
6
|
NT$54.70 | Buy/Sell | NT$0.00 | -100.00% |
| 3705 Stock Forecast | YungShin Global Holding | - |
18
|
NT$46.70 | Buy/Sell | NT$0.00 | -100.00% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 4119 Stock Forecast | SCI Pharmtech | - |
18
|
NT$88.50 | Buy/Sell | NT$116.44 | -100.00% |
| 3266 Stock Forecast | Sunty Development Co., LTD | - |
15
|
NT$24.20 | Buy/Sell | NT$0.00 | -100.00% |
| 1701 Stock Forecast | China Chemical & Pharmaceutica... | - |
16
|
NT$23.60 | Buy/Sell | NT$0.00 | -100.00% |
Panion & Bf Biotech EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Panion & Bf Biotech's EBITDA has increased by 241.03%, going from NT$160.18M to NT$546.26M. According to 0 prominent analysts, Panion & Bf Biotech's EBITDA will fall by 46.99% in the next year, reaching NT$289.59M. By 2030, professionals believe that Panion & Bf Biotech's EBITDA will decrease by 33.76%, reaching NT$361.83M – a concerning trend for the company.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 6575 Stock Forecast | SyneuRx International (Taiwan) | - |
9
|
NT$48.95 | Buy/Sell | NT$0.00 | -100.00% |
| 1734 Stock Forecast | Sinphar Pharmaceutical | - |
8
|
NT$36.40 | Buy/Sell | NT$24.00 | -100.00% |
| 6634 Stock Forecast | Sinew Pharma | - |
7
|
NT$56.00 | Buy/Sell | NT$0.00 | -100.00% |
Panion & Bf Biotech EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Panion & Bf Biotech's EBIT has grown, increasing from NT$104.50M to NT$413.96M – an increase of 296.13%. In the following year, 0 experts forecast Panion & Bf Biotech's EBIT will decrease by 52.31%, to NT$197.43M. In 2030, professionals predict that Panion & Bf Biotech's EBIT will decrease by 35.18%, to NT$268.34M.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 6657 Stock Forecast | Energenesis Biomedical CO.,LTD... | - |
8
|
NT$54.30 | Buy/Sell | NT$0.00 | -100.00% |
| 4108 Stock Forecast | PhytoHealth | - |
4
|
NT$19.60 | Buy/Sell | NT$36.50 | -100.00% |
| 4166 Stock Forecast | Orient Pharma | - |
4
|
NT$20.55 | Buy/Sell | NT$0.00 | -100.00% |
Panion & Bf Biotech EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last two years, Panion & Bf Biotech's EPS has decreased from NT$0.36 to NT$0.00 – a 100.00% drop! In the next year, analysts believe that EPS will reach NT$0.00 – an increase of 100.00%. For the next six years, the forecast is forEPS to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 1752 Stock Forecast | Nang Kuang Pharmaceutical | - |
18
|
NT$48.40 | Buy/Sell | NT$0.00 | -100.00% |
| 6461 Stock Forecast | Intech Biopharm | - |
5
|
NT$30.80 | Buy/Sell | NT$0.00 | -100.00% |
| 1731 Stock Forecast | Maywufa | - |
16
|
NT$24.95 | Buy/Sell | NT$14.00 | -100.00% |
.jpg)